page_title: Malaria Atlas Project
section_title: Plasmodium falciparum prevalence maps
hierarchical_section_title: Malaria Atlas Project / Academic research / Modelling malaria prevalence / Plasmodium falciparum prevalence maps
caption_attribution_description: English: The spatial distribution of Plasmodium falciparum malaria endemicity in 2010. Panel A shows the 2010 spatial Limits of P. falciparum malaria risk defined by PfAPI with further medical intelligence, temperature and aridity Masks. Areas were defined as stable (dark grey areas, where PfAPI ≥0.1 per 1,000 pa), unstable (medium grey areas, where PfAPI &lt; 0.1 per 1,000 pa) or no risk (light grey, where PfAPI = 0 per 1,000 pa). The community surveys of P. falciparum prevalence conducted between January 1985 and June 2010 are plotted. Of the 23,612 surveys collected, 22,212 satisfied the inclusion criteria for modelling (see Methods and Additional File 1, 2) and are shown here. The survey data are age-standardized [40] (PfPR2-10) and presented as a continuum of blue to red from 0%-100% (see map legend), with zero-valued surveys shown in white. Panel B shows the MBG point estimates of the annual mean PfPR2-10 for 2010 within the spatial limits of stable P. falciparum malaria transmission, displayed on the same colour scale. Areas of no risk or unstable risk are as in (A).
context_page_description: The Malaria Atlas Project, abbreviated as MAP, is a non-profit academic group led by Professor Peter Gething, Kerry M Stokes Chair in Child Health, at the Telethon Kids Institute, Perth, Western Australia. The group is funded by the Bill and Melinda Gates Foundation, with previous funding also coming from the Medical Research Council and the Wellcome Trust.
  MAP aims to disseminate free, accurate and up-to-date information on malaria and associated topics, organised on a geographical basis.
  The work of MAP falls into three areas:
  The estimation of the spatial distribution of malaria prevalence and incidence and related topics such as the spatial distribution of insecticide treated nets, antimalarial drugs, mosquito vectors, and human blood disorders
  Disseminating data on malaria via the Repository for Open Access Data project
  Providing maps relating to malaria prevalence and related topics for the World Health Organization and other bodies.
context_section_description: Since the year 2000, a concerted campaign against malaria has led to unprecedented levels of intervention coverage across sub-Saharan Africa. Future control planning depends on understanding the effect of this effort. However, the effect of malaria interventions across the varied epidemiological settings of Africa remains poorly understood owing to the absence of reliable surveillance data and the simplistic approaches underlying current disease estimates.
  In September 2015, research by MAP published in Nature quantified the attributable effect of malaria disease control efforts in Africa. The results showed Plasmodium falciparum infection prevalence in endemic Africa halved and the incidence of clinical disease fell by 40% between 2000 and 2015.  The best estimate is that interventions have averted 663 million clinical cases since 2000. Insecticide-treated nets, the most widespread intervention, were by far the largest contributor. Although still below target levels, current malaria interventions have substantially reduced malaria disease incidence across the continent.
caption: World map of Plasmodium falciparum endemicity in 2010
exif: {}